ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN JAGODA | — |
| JAMES PATRICK PALUSKIEWICZ | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
Medicare/Medicaid MMM
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES PATRICK PALUSKIEWICZ | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
Pharmacy PHA
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Medical/Disease Research/Clinical Labs MED
H.R.10571, Surge to Save Newborns Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN JAGODA | — |
| JAMES PATRICK PALUSKIEWICZ | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
Taxation/Internal Revenue Code TAX
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
Trade (domestic/foreign) TRD
Treatment of orphan drugs under tariff proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.